Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Celator Pharmaceuticals Inc (CPXX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 02/15/2017 |
SC 13G/A
| Thomas, McNerney & Partners II L.P. reports a 0% stake in Celator Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| QUAKER BIO VENTURES LP reports a 0% stake in Celator Pharmaceuticals, Inc. |
| 01/30/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 08/02/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/27/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/22/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 07/15/2016 |
SC 13D/A
| CAXTON CORP reports a 0% stake in Celator Pharmaceuticals, Inc. |
| 07/13/2016 |
4
| Kollender Richard S (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Exercised (in-or-at-the-money) 40,614 shares
@ $0
Exercised (in-or-at-the-money) 47,265 shares
@ $0
Unknown transaction of 1,327,888 shares
@ $30.25, valued at
$40.2M
Unknown transaction of 637,962 shares
@ $30.25, valued at
$19.3M
Exercised (in-or-at-the-money) 16,391 warrants
@ $5.2123, valued at
$85.4k
Exercised (in-or-at-the-money) 19,076 warrants
@ $5.2123, valued at
$99.4k
Exercised (in-or-at-the-money) 30,708 warrants
@ $3.58, valued at
$109.9k
Exercised (in-or-at-the-money) 35,737 warrants
@ $3.58, valued at
$127.9k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 14,000 options to buy
@ $2.6, valued at
$36.4k
|
|
| 07/12/2016 |
4
| Kovner Bruce (See Remarks Section) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Unknown transaction of 1,591,750 shares
@ $30.25, valued at
$48.2M
Unknown transaction of 564,222 shares
@ $30.25, valued at
$17.1M
Disposed of 34,647 warrants
@ $5.2123, valued at
$180.6k
Disposed of 889,403 warrants
@ $3.58, valued at
$3.2M
|
|
| 07/12/2016 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed/sold 6,277 shares
@ $30.25, valued at
$189.9k
Unknown transaction of 1,039,109 shares
@ $30.25, valued at
$31.4M
Disposed/sold 14,000 options to buy
@ $2.6, valued at
$36.4k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 358 warrants
@ $3.58, valued at
$1.3k
Unknown transaction of 314,611 warrants
@ $3.58, valued at
$1.1M
|
|
| 07/12/2016 |
4
| Valence Life Sciences GP II LLC (Member of a 10% Group) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed of 44,740 warrants
@ $3.58, valued at
$160.2k
Unknown transaction of 1,039,109 shares
@ $30.25, valued at
$31.4M
Unknown transaction of 143,986 shares
@ $30.25, valued at
$4.4M
Disposed of 314,611 warrants
@ $3.58, valued at
$1.1M
|
|
| 07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/12/2016 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 07/12/2016 |
4
| Lobacki Joseph M (Director) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 07/12/2016 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 07/12/2016 |
4
| MOLLICA JOSEPH A (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed/sold 26,668 options to buy
@ $3.37, valued at
$89.9k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 14,000 options to buy
@ $2.6, valued at
$36.4k
|
|
| 07/12/2016 |
4
| DOUGHERTY MICHAEL R (Executive Chairman) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed/sold 20,000 shares
@ $30.25, valued at
$605k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 20,600 options to buy
@ $2.65, valued at
$54.6k
Disposed/sold 22,000 options to buy
@ $2.6, valued at
$57.2k
Disposed/sold 500,000 options to buy
@ $2.18, valued at
$1.1M
Disposed/sold 75,000 options to buy
@ $1.32, valued at
$99k
Disposed/sold 17,457 options to buy
@ $1.32, valued at
$23k
|
|
| 07/12/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/12/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/12/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/12/2016 |
8-K
| Quarterly results |
| 07/12/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 07/12/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 07/07/2016 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Exercised 38,135 options to buy
@ $3.37, valued at
$128.5k
Exercised 117,064 options to buy
@ $2.44, valued at
$285.6k
Exercised 96,276 options to buy
@ $3.116, valued at
$300k
|
|
| 07/07/2016 |
4
| Powell Fred M (VP and CFO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Exercised 71,887 options to buy
@ $3.116, valued at
$224k
|
|
| 07/06/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 07/01/2016 |
4
| Powell Fred M (VP and CFO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Gifted 1,665 shares
@ $0 |
|
| 06/29/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 06/27/2016 |
4
| Powell Fred M (See Remarks) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 2,491 shares
@ $30.15, valued at
$75.1k
Exercised 56,875 options to buy
@ $1.32, valued at
$75.1k
|
|
| 06/27/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 06/22/2016 |
SC 13D/A
| CAXTON CORP reports a 7.2% stake in Celator Pharmaceuticals, Inc. |
| 06/22/2016 |
4
| Kovner Bruce (See Remarks Section) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Gifted 88,571 shares
@ $0
Gifted 564,222 shares
@ $0
Gifted 564,222 shares
@ $0
Gifted 1,926 shares
@ $0 |
|
|
|
|